TNPSC Thervupettagam

Shingrix Vaccine

May 2 , 2023 575 days 546 0
  • GlaxoSmithKline Pharmaceuticals Ltd. (GSK) announced the launch of its shingles vaccine in India.
  • The vaccine, named Shingrix, is one of the best-selling products of the company.
  • Shingles is a viral infection that causes a painful rash and it can occur anywhere in the body.
  • This is caused by the varicella-zoster virus.
  • Shingrix is the world’s first non-live, recombinant subunit vaccine that is given intramuscularly in two doses.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories